Non-Invasive Prenatal Test (NIPT) are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for fetal aneuploidies. Currently, the prenatal testing market is experiencing a paradigm shift from conventional prenatal screening and diagnostic methods to non-invasive prenatal testing. This is mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities. Browse Full Report With TOC @ http://www.researchmoz.us/noninvasive-prenatal-testing-nipt-market-panorama-bambni-test-harmony-maternit21-plus-nifty-prenatest-verifi-visibilit-informaseq-veracity-iona-test-global-market-analysis-size-volume-share-growth-trends-and-forecast-2011-2021-report.html
http://www.researchmoz.us/noninvasive-prenatal-testing-nipt-market-panorama-bambni-test-harmony-maternit21-plus-nifty-prenatest-verifi-visibilit-informaseq-veracity-iona-test-global-market-analysis-size-volume-share-growth-trends-and-forecast-2011-2021-report.html
No comments:
Post a Comment